Federal Court of Justice restricts advertising with new infectious diseases

Federal Court of Justice restricts advertising with new infectious diseases

According to a report from www.presseportal.de,

In a new ruling, the Federal Court of Justice has restricted advertising with new infectious diseases. The North Rhine-Westphalia consumer advice center has successfully taken action against the manufacturer of the “Linola sept” mouthwash, which illegally promised “corona prophylaxis” for its mouthwash. The BGH made it clear that there is also an advertising ban for new infectious diseases such as Covid-19.

The BGH's decision has far-reaching effects on the market and consumers. Companies can no longer arbitrarily use new infectious diseases in their advertising, and consumers are better protected from misleading or unauthorized health advertising. The North Rhine-Westphalia Consumer Center is satisfied with the verdict and emphasizes that manufacturers are not allowed to do business by advertising their products with promises of healing for dangerous new infectious diseases such as Covid-19.

This ruling makes the interpretation of the Medicines Advertising Act and the Infection Protection Act clearer, and the court decision creates a legal basis to take action against inadmissible health advertising. Companies must now strictly adhere to legal requirements and are no longer allowed to use new infectious diseases in their advertising, which leads to greater transparency and safety for consumers. The ruling also strengthens the position of consumer advice centers, which are working together to combat unfair competitive behavior in the health sector.

Overall, this ruling by the Federal Court of Justice will help protect consumers from deceptive health advertising and clarify the legal basis for dealing with new infectious diseases in advertising.

This development shows that case law is keeping pace with current health challenges and is setting clear limits on the advertising of health products that are in the interests of consumers.

As reported by www.presseportal.de, the Federal Court of Justice has restricted advertising with new infectious diseases. The North Rhine-Westphalia consumer advice center successfully took action against the manufacturer of the mouthwash “Linola sept”, which had illegally promised “corona prophylaxis” for its mouthwash. The BGH made it clear that there is also an advertising ban for new infectious diseases such as Covid-19. The decision has far-reaching implications for the market and consumers. Companies can no longer indiscriminately advertise new infectious diseases, and consumers are better protected from misleading or unauthorized health advertising. The NRW consumer advice center is satisfied and emphasizes that manufacturers are not allowed to do business by advertising promises of cure for dangerous new infectious diseases such as Covid-19. This ruling makes the interpretation of the Medicines Advertising Act and the Infection Protection Act clearer, and the court decision creates a legal basis to take action against inadmissible health advertising. Companies must now strictly adhere to legal requirements and are no longer allowed to use new infectious diseases in their advertising, which leads to greater transparency and safety for consumers. The ruling also strengthens the position of consumer advice centers, which are working together to combat unfair competitive behavior in the health sector. Overall, this ruling by the Federal Court of Justice will help protect consumers from deceptive health advertising and clarify the legal basis for dealing with new infectious diseases in advertising. This development shows that case law is keeping pace with current health challenges and is setting clear limits on the advertising of health products that are in the interests of consumers.